Novogyne Combipatch
Executive Summary
Direct mailing to about 22,000 pharmacists highlights "no need for patients to refrigerate" the estrogen/progestin patch. Combipatch should be kept refrigerated prior to dispensing, Novogyne said. The Novartis/Noven joint venture is re-launching Combipatch, approved in August 1998, with its 120-rep sales force. Novogyne acquired the product from Aventis in March for about $65 mil